| Date | Form | Description | Docs | XBRL | Pages |
| 06/19/19 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 06/18/19 | UPLOAD | SEC-generated letter |
|
1 | |
| 06/12/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
| 06/11/19 | S-3 | Registration statement for specified transactions by certain issuers |
|
137 | |
| 05/23/19 | 8-K | Current report filing |
|
25 | |
| 05/02/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/26/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
Read More...Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Read More...